| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $219.1M | +3.3% | +9.2% |
| Cost of Revenue | $73.6M | +9.1% | +27.3% |
| Gross Profit | $145.5M | +0.6% | +1.8% |
| R&D Expense | $24.7M | +6.7% | +6.1% |
| SG&A Expense | $33.7M | -5.3% | -1.3% |
| Operating Income | $11.6M | -29.0% | +46.4% |
| Pre-tax Income | $17.3M | -27.1% | +29.4% |
| Income Tax | $14.4M | +29.5% | +392.0% |
| Net Income | $2.9M | -77.0% | -72.2% |
| EPS (Basic) | $0.01 | -80.0% | -75.0% |
| EPS (Diluted) | $0.01 | -80.0% | -75.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $189.6M | +51.2% | +103.3% |
| Current Assets | $735.6M | -4.1% | +0.8% |
| Total Assets | $1.05B | -3.0% | +8.6% |
| Current Liabilities | $444.1M | -10.1% | +6.0% |
| Total Liabilities | $495.8M | -8.6% | +4.8% |
| Stockholders' Equity | $558.1M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $138.5M | — | — |
| Capital Expenditures | $839K | — | — |
| Investing Cash Flow | $39.2M | — | — |
| Financing Cash Flow | -$135.6M | — | — |
| Free Cash Flow | $137.7M | — | — |
| +12.3% |